Seattle Genetics | Le Bénéfice D'Exploitation



Le Bénéfice D'Exploitation Changement Date
AbbVie USD 5.81B 1.23B 2025-12
Acadia Pharmaceuticals USD 35.76M 3.38M 2025-09
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
Amgen USD 3.96B 464M 2025-12
Astellas Pharma JPY 134.54B 30.13B 2025-12
Bayer EUR -543M 556M 2025-09
Biogen USD 659.6M 192.2M 2025-09
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Celldex Therapeutics USD -73.62M 9.76M 2025-09
Daiichi Sankyo JPY 89.54B 42.01B 2025-12
Eisai JPY 20.03B 6.36B 2025-12
Eli Lilly USD 8.99B 599.9M 2025-12
Esperion Therapeutics USD -16.03M 18.6M 2024-09
Exelixis USD 235.91M 20.45M 2025-12
Genmab DKK 360M 172M 2025-06
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Glaxosmithkline GBP 3.76B 1.32B 2025-09
Incyte USD 383.88M 47.43M 2025-12
Insmed USD -261.35M 7.48M 2025-09
Karyopharm Therapeutics USD -31.28M 5M 2024-12
MacroGenics USD 18.64M 55.4M 2025-09
Merck USD 6.24B 318M 2025-12
Moderna USD -260M 647M 2025-09
Nektar Therapeutics USD -34.34M 15.43M 2024-09
Novartis USD 4.5B 363M 2025-09
Pfizer USD 4.65B 3.99B 2025-12
Puma Biotechnology USD 22.08M 24.26M 2024-09
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
Takeda JPY 168.82B 479.89B 2025-12
Teva Pharmaceutical Industries USD 487M 581M 2025-12
Vertex Pharmaceuticals USD 1.24B 84.6M 2025-09
Xencor USD -47.52M 14.35M 2025-09


Seattle Genetics Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.